How Hydrea Helps Manage Resistant Chronic Myeloid Leukemia (CML)
مرسل: الثلاثاء مايو 27, 2025 8:32 am
Hydrea (also called hydroxyurea) is a medicine that helps manage resistant chronic myeloid leukemia (CML), especially when other treatments don’t work well. CML is a type of blood cancer that causes the body to make too many white blood cells. These abnormal cells grow and multiply quickly, making it hard for the body to fight infections and stay healthy.
Hydrea works by slowing down the growth of cancer cells in the bone marrow. It reduces the number of white blood cells, helping the blood return to more normal levels. This can improve symptoms like fatigue, fever, and pain in the spleen.
Read more: Specialitymedz
Hydrea works by slowing down the growth of cancer cells in the bone marrow. It reduces the number of white blood cells, helping the blood return to more normal levels. This can improve symptoms like fatigue, fever, and pain in the spleen.
Read more: Specialitymedz